Dana-farber Cancer Institute

This study tested two immunotherapy drugs, durvalumab and tremelimumab, in people with malignant pleural mesothelioma, a rare cancer of the lung lining. The trial included 19 adults whose cancer had worsened after standard chemotherapy. The goal was to see if the drug combination…

This study tested a drug called neratinib, alone or with another drug (fulvestrant), in people with a specific advanced breast cancer (HER2-positive and ER-positive). The goal was to see if the combination could slow cancer growth. The study was stopped early after enrolling 21 p…

This study tested two immunotherapy drugs, ipilimumab and nivolumab, as the first treatment for people with advanced non-small cell lung cancer that had spread. The goal was to see how well the drugs worked and to find markers that predict response. Only 5 people enrolled before …